Glycan Profiling Analysis of Equine Amniotic Progenitor Mesenchymal Cells and Their Derived Extracellular Microvesicles.

This research investigates the presence of glycoconjugates — a type of carbohydrate — on the surface of equine amniotic mesenchymal cells (eAMCs) and the small vesicles they release. The study discovered that certain glycoconjugates may serve as markers for these cells and the vesicles they produce, which play a significant role in healing various horse injuries.

Understanding eAMCs and Their Role

• Equine amniotic mesenchymal cells (eAMCs) are cells that play vital roles in repairing tissue damage. They are especially helpful in healing equine tendon injuries and endometrial inflammation in horses.
• The eAMCs release small vesicles, known as extracellular vesicles (EVs), which are fundamental to many biological processes, most notably in tissue repair mechanisms.

Glycoconjugates and Cellular Recognition

• Glycoconjugates are substances composed of proteins and carbohydrates. They are crucial for cellular recognition, making it possible for cells to ‘know’ and interact with each other.
• Glycoconjugates also play a role in efficient uptake of extracellular vesicles (EVs) by other cells. This is how cells communicate and share information, contributing to healing processes.

The Study Procedure and Findings

• The researchers used a microarray procedure to evaluate the surface glycosylation pattern of eAMCs and their EVs. This involved spotting eAMCs and EVs on slides, then marking them with specific substances called lectins and a fluorescent marker.
• Using a microarray scanner, they were able to detect the interaction between the lectins and the cells or vesicles, indicating the presence of certain glycoconjugates (N- and O-linked glycans).
• The vesicles (eAMC-EVs) were revealed to be enriched with specific glycoconjugates (namely Galβ1,3GalNAc terminating O-glycans, α2,3-linked sialoglycans, and high-mannose N-glycans) which could serve as markers for identifying these eAMC-EVs.
• However, other types of glycoconjugates (N-acetyllactosamine, GalNAc, Gal, GlcNAc, and fucose terminating glycans) were found in lower amounts in the vesicles.

Significance of the Findings and Future Research Need

• The finding suggests these vesicles come from a specific eAMC microdomain. This could help in identifying and targeting these cells for therapeutic purposes.
• Despite interesting results, the role of these identified sugars in equine regenerative medicine is still unclear, necessitating further research to understand their specific contributions to the healing process.